TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/10/2024
Back to search
Official data from USPTO
IMPROVING LIVES WITH PRECISION DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMPROVING LIVES WITH PRECISION DIAGNOSTICS
ST13
US500000088153684Class
1, 5, 42, 44
Filing
88153684
Registration
6789818
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
10/15/2024
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
10/12/2018
Registration date
07/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2022
Last transaction
10/15/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/10/2018
First use in commerce
10/10/2018
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
KETCHUM, BRENDAN
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Invivoscribe, Inc.
Representatives
Sarah W. Matthews Dentons Durham Jones Pinegar
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for scientific and research usebuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in polymerase chain reactionDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in polymerase chain reactionDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for researchclinical researchlaboratory research use
Class 5
Assays for the treatment or diagnosis of disease; medical diagnostic reagentsbuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in polymerase chain reactionDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic kits comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in polymerase chain reactionDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatmentmonitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
Class 42
DNA analysis services for scientific research purposesDNA sequencingbioinformatics analysisinterpretation of biological DNA data generated from reagents and assays; providing medical testing and consultation services for both clinical research and research applications
Class 44
DNA screening for medical purposesDNA sequencingbioinformatics analysisinterpretation of biological DNA data generated from reagents and assays; providing information services regarding the diagnosismonitoring and options in the treatment of leukemia; providing medical testing and consultation services for clinical applications
Publications
History of USPTO decisions and trademark events.
44 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/07/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/06/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/16/2022
IUAF
USE AMENDMENT FILED
05/13/2022
EISU
TEAS STATEMENT OF USE RECEIVED
05/13/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/23/2021
EX5G
SOU EXTENSION 5 GRANTED
11/20/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/20/2021
EXT5
SOU EXTENSION 5 FILED
11/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/15/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/22/2021
EX4G
SOU EXTENSION 4 GRANTED
05/20/2021
EXT4
SOU EXTENSION 4 FILED
05/20/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/20/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/18/2020
EX3G
SOU EXTENSION 3 GRANTED
11/16/2020
EXT3
SOU EXTENSION 3 FILED
11/16/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/16/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/22/2020
EX2G
SOU EXTENSION 2 GRANTED
05/20/2020
EXT2
SOU EXTENSION 2 FILED
05/20/2020
EEXT
SOU TEAS EXTENSION RECEIVED
05/20/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/23/2019
EX1G
SOU EXTENSION 1 GRANTED
11/21/2019
EXT1
SOU EXTENSION 1 FILED
11/21/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/21/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/21/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2019
PUBO
PUBLISHED FOR OPPOSITION
03/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2019
ALIE
ASSIGNED TO LIE
02/15/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/30/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
01/30/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/30/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
01/30/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/30/2019
DOCK
ASSIGNED TO EXAMINER
01/23/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/24/2018
NWAP
NEW APPLICATION ENTERED
10/16/2018
Continuous trademark protection
Get notified about every new filing that threatens IMPROVING LIVES WITH PRECISION DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.